|
1 Kuang SQ, Liao L，Wang S, et al. Mice lacking the amplified in breast cancer 1/steroid receptor coactivator-3 are resistant to chemical carcinogen-induced mammary tumorigenesis. Cancer Res,2005,65(17):7993-8002.
|
|
2 Minna K，Tikkanen，Damien J, et al. Endogenously expressed estrogen receptor and coactivator AIBl interact in MCF-7 human breast cancer cells. Proc Natl Acad Sci USA，2000，97(23)：12536-12540.
|
|
3 Ralf TH，Bassem R，Haddad SEK，et al. Overexpression of the nuclear receptor coactivator AIBl (SRC-3) during progression of pancreatic adenocarcinoma. Clin Cancer Res,2004,10：6134-6142.
|
|
4 Xu J, Liao L, Ning G,et al. The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIBl/ACTR/TRAM-l) is required for normal growth, puberty, female reproductive function, and mammarygland development. Proc Natl Acad Sci USA,2000，97(12)：6379-6384.
|
|
5 Anzick SL, Kononen J，Walker RL，et al. AIBl，a steroid receptorcoactivator amplified in breast and ovarian cancer. Science，1997，277:965-968.
|
|
6 David O. Azorsa P, Meltzer S. Production and characterization of monoclonal antibodies to the steroid receptor coactivator AIBl. Hybridoma, 1999, (18)：281-287.
|
|
7 Liao L, Kuang SQ, Yuan Y, et al. Molecular structure and biological function of the cancer-amplified nuclear receptor coactivator SRC-3/AIB1. J Steroid Biochem Mol Biol, 2002,83 (1-5) :3-14.
|
|
8 Hudelist G，Czerwenka K，Kubista E, et al. Expression of sex steroid receptors and their co-factors in normal and malignant breast tissue：AIBl is a carcinoma-specific co-activator. Breast Cancer Res Treat, 2003,78(2)：193-204.
|
|
9 Sarraf S，Tejada R, Abawi M, et al. The human ovarianteratocarcinoma cell line PA-1 demonstrates a single translocation：Analysis with fluorescence in situ hybridization, spectral karyotyping, and bacterial artificial chromosome microarray. Cancer Genet Cytogenet, 2005，161 (1): 63-69.
|
|
10 Anzick SL，Azorsa DO, Simons SS，et al. Phenotypic alterationsin breast cancer cells overexpressing the nuclear receptor co¬activator AIBl. BMC Cancer,2003, 3：22.
|
|
11 Font de Mora J，Brown M. AIBl is a conduit for kinase-mediated growth factor signaling to the estrogen receptor. Mol Cell Biol,2000,20(14)：5041-5047.
|
|
12 Kuang SQ, Liao L, Zhang H, et al. AIBl/SRC-3 deficiency affects insulin-like growth factor I signaling pathway and suppresses v-Ha-ras-induced breast cancer initiation and progression in mice. Cancer Res,2004,64：1875-1885.
|
|
13 Minna M. Tanner S，Grenman AK, et al. Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer. Clin Cancer Res,2000, 6:1833-1839.
|